2TD-31448-45289
2 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 782 / TX
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- HHF-10552-48378
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Registered in v-safe
-
2022-06-22
Dose 1 — Moderna
- 2022-06-22
-
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · SleepinessUnder 3 check-in
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-28
- 2022-06-29
- 2022-07-06
-
2022-07-13
Survey response — day 21, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Rhinorrea x 2.5 days (7/10-12/22MedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Dose 2 — Moderna
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
-
2022-07-29
Health check-in — day 7, dose 2, under 3Feeling: Fair · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend schoolUnder 3 check-in
- 2022-08-05
- 2022-08-12
- 2022-08-19
- 2022-08-26
-
2022-09-02
Survey response — day 42, dose 2, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Hand foot and mouth diseaseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-02
Report sent to call center — day 42, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-06
-
2022-09-06
Call successfulNot applicable - Accidental Reporting
- 2022-10-21
- 2023-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-02 | Successful 2022-09-06 |
Not applicable - Accidental Reporting |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Rhinorrea x 2.5 days (7/10-12/22
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Hand foot and mouth disease
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release